CAFC Clarifies PTA After Interference in Mayo v. Iancu
December 2, 2019
Authored and Edited by Michael Liu Su; Justin J. Hasford
In Mayo Foundation for Medical Education and Research v. Iancu, No. 2018-2031 (Fed. Cir. Sept. 16, 2019), the Federal Circuit affirmed the district court’s decision that Patent Term Adjustment is reduced by the period after an interference concludes and the issuance of a notice of allowance, where the interference follows the filing of a Request for Continued Examination. The court rejected Mayo’s argument that an interference is equivalent to a Notice of Allowance because claims must be “deemed allowable” to enter an interference. The court explained that the “[USPTO] regulations as a whole do not indicate that a declaration of an interference is tantamount to a Notice of Allowance.” Judge Newman dissented, reasoning that Mayo had not requested further examination after the interference and that the majority’s result is contrary to patent policy. Further discussion of the decision can be found on Finnegan’s Federal Circuit IP Blog.
drugs, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO)
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Federal Circuit IP Blog
Federal Circuit Clarifies Reach of Patent Estoppel in SoftView v. Apple
August 8, 2024
Webinar
January 11, 2024
Webinar
Webinar
November 28, 2023
Webinar
Webinar
October 16, 2023
Webinar
Prosecution First Blog
USPTO’s Updates on PTA Practice and “Safe Harbor” of § 1.704(d)
July 28, 2023
At the PTAB Blog
IOENGINE Ruling Helps Clarify the Application of Collateral Estoppel to PTAB Decisions of Invalidity
July 10, 2023
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.